Multicenter randomized comparison between fractional flow reserve guidance and intravascular ultrasound guidance for optimizing drug-eluting stent implantation.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 28 Dec 2016
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 26 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 04 May 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 04 Nov 2011 New trial record